InfuSystem Holdings Inc  

(Public, NYSEMKT:INFU)   Watch this stock  
Find more results for NYSEAMEX:INFU
-0.01 (-0.38%)
Feb 27 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 2.63 - 2.66
52 week 2.47 - 4.50
Open 2.65
Vol / Avg. 22,165.00/24,150.00
Mkt cap 58.83M
P/E 18.55
Div/yield     -
EPS 0.14
Shares 22.28M
Beta 0.61
Inst. own 71%
Dec 2, 2014
InfuSystem Holdings Inc at LD Micro Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 5.13% 2.68%
Operating margin 14.71% 9.47%
EBITD margin - 22.37%
Return on average assets 4.31% 2.15%
Return on average equity 7.62% 4.03%
Employees 198 -
CDP Score - -


31700 Research Park Drive
United States - Map
+1-248-5467047 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


InfuSystem Holdings, Inc. is a provider of infusion pumps and related services. The Company provides its services to hospitals, oncology practices and facilities and other alternate sites healthcare providers. The Company's core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer. The Company provides these pumps and related supplies to oncology clinics, obtains an assignment of insurance benefits from the patient and bills the patient's insurance company or patient as appropriate, for the use of the pump and supplies, and collect payment. The Company also provides pump management services for the pumps and associated disposable supply kits to approximately 1,400 oncology clinics in the United States.

Officers and directors

Eric Steen President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Jonathan P. Foster Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Janet Skonieczny Chief Operating Officer, Chief Compliance Officer and Privacy Officer
Age: 55
Bio & Compensation  - Reuters
Michael McReynolds Chief Information Officer
Age: 45
Bio & Compensation  - Reuters
Thomas F. Creal II Executive Vice President of First Biomedical
Age: 66
Bio & Compensation  - Reuters
Ryan J. Morris Non-Executive Chairman of the Board
Age: 30
Bio & Compensation  - Reuters
Gregg O. Lehman Ph.D. Director
Age: 66
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 58
Bio & Compensation  - Reuters
Joseph E. Whitters Independent Director
Age: 56
Bio & Compensation  - Reuters
Wayne P. Yetter Independent Director
Age: 69
Bio & Compensation  - Reuters